Akoya to Participate at Two Upcoming Investor Conferences
2023年6月13日 - 5:05AM
Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial
Biology Company®, today announced that Company management will be
participating in two upcoming investor conferences.
- Capital One Securities 2nd
Annual Spatial Biology and Proteomics Virtual Research
Summit“Pushing the Envelope of Technology with Increased
Sensitivity and Higher Plex on the Horizon” Panel on Tuesday, June
20th at 10:30 AM ETNiro Ramachandran, CBO
- TD Cowen 2nd Annual
Tools/Dx Revolution“Spatial – The Next Frontier: Clinical”
Panel on Monday, June 26th at 4:20 PM PTBrian McKelligon, CEO
A live and archived webcast of the Capital One event will be
available on the “Investors” section of the Akoya website at
https://investors.akoyabio.com/.
About Akoya BiosciencesAs The Spatial Biology
Company®, Akoya Biosciences’ mission is to bring context to the
world of biology and human health through the power of spatial
phenotyping. The company offers comprehensive single-cell imaging
solutions that allow researchers to phenotype cells with spatial
context and visualize how they organize and interact to influence
disease progression and response to therapy. Akoya offers a full
continuum of spatial phenotyping solutions to serve the diverse
needs of researchers across discovery, translational and clinical
research via its key platforms: PhenoCycler™, PhenoImager™ Fusion
and PhenoImager HT. To learn more about Akoya,
visit www.akoyabio.com.
Investor Contact:Priyam ShahSr. Director,
Investor RelationsAkoya Biosciences, Inc.investors@akoyabio.com
Media Contact:Christine Quern(617)
650-8497media@akoyabio.com
Akoya BioSciences (NASDAQ:AKYA)
過去 株価チャート
から 4 2024 まで 5 2024
Akoya BioSciences (NASDAQ:AKYA)
過去 株価チャート
から 5 2023 まで 5 2024